CLASS II (IA) EXPRESSION BY ACTIVATED T CELLS
CLASS II (IA) EXPRESSION BY ACTIVATED T CELLS
批准号:
3135738
负责人:
KAREN S ZIER
金额:
$8.17万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-07-01 至 1989-11-30
中文摘要
在人类白细胞抗原复合体中编码的抗原起着重要的作用
在控制免疫反应中的作用。目前,有三大
可以定义人类白细胞抗原的类别:1)I类产品,
由人类白细胞抗原A、B和C基因座编码,2)II(Ia)类产物,
由HLA-DR、DQ和DP基因座编码和3)III类产物
该代码用于补充级联中涉及的组件。
所有的单核血细胞都表达I类抗原。
然而,II类抗原的组织分布有限。
它们由B细胞、单核细胞和活化的BUT表达
而不是通过静息T细胞。
长期以来,人们一直意识到II(Ia)类分子表达
在单核细胞和B细胞上负责调节
免疫系统。具体地说,它们在以下方面发挥了关键作用
抗原递呈,2)T细胞和T细胞之间的通讯
B细胞和T细胞与巨噬细胞之间,以及3)在影响
易患某些疾病。而第二类表达式由
最近的证据表明,激活的T细胞还没有得到很好的研究
提示它们可能参与T细胞功能。为
例如,据报道,添加抗II类药物
单抗可抑制活化T细胞的增殖
细胞。这表明T细胞上的II类抗原可能
影响触发细胞的信号的传输
增殖和功能能力的发展。这个
这项建议的主要目的是界定
II类基因表达与T细胞活化和功能的关系。
我们将通过研究单词的转录来实现我们的目标
三种类型的II类基因(DR、DQ、DP)与两个
在T细胞激活过程中启动的其他基因,IL-2分子
和它的受体(Tac),以及与启动
扩散,2)并通过检查是否有定性的
或数量上的差异积累的第II类基因的mRNA
通过具有不同功能活性的T细胞克隆。澄清
类风湿因子II类基因表达的机制及意义
活化的T细胞将对人类免疫系统的设计产生重大影响
基础研究中免疫调节的新方法
就像在临床环境中一样。
英文摘要
Antigens coded for within the HLA complex play an important
role in the control of immune responses. Presently, three major
classes of HLA antigens can be defined: 1) Class I products,
coded for by the HLA-A,B, and C loci, 2) Class II (Ia) products,
coded for by the HLA-DR,DQ and DP loci and 3) Class III products
which code for components involved in the complement cascade.
Class I antigens are expressed by all mononuclear blood cells.
Class II antigens, however, have a limited tissue distribution.
They are expressed by B cells, monocytes, and by activated but
not by resting T cells.
It has long been appreciated that Class II (Ia) molecules expressed
on monocytes and B cells are responsible for the regulation of the
immune system. Specifically, they play a critical role 1) in
antigen presentation, 2) in the communication between T cells and
B cells and between T cells and macrophages, and 3) in influencing
susceptibility to certain diseases. While Class II expression by
activated T cells has not been well studied, recent evidence
suggests that they may be involved in T cell function. For
example, it was reported that the addition of anti-Class II
monoclonal antibodies inhibited the proliferation of activated T
cells. This suggested that Class II antigens on T cells might
influence the transmission of signals which trigger cell
proliferation and the development of functional ability. The
principal aim of this proposal is to define the relationship between
Class II gene expression and T cell activation and function.
We will achieve our goal 1) by studying the transcription of the
three types of Class II genes (DR, DQ, DP) in relation to two
other genes turned on during T cell activation, the IL-2 molecule
and its receptor (Tac), and in relation to the initiation of
proliferation, 2) and by examining whether there are qualitative
or quantitative differences in the accumulation of Class II mRNA
by T cell clones with different functional activities. Elucidating
the mechanism and significance of Class II gene expression in
activated T cells will have major implications on the design of
new approaches for immunomodulation in basic research, as well
as in clinical settings.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ABNORMAL TCR/CD3 SIGNAL TRANSDUCTION IN CANCER
-
批准号:2104722
-
项目类别:
-
资助金额:$19.38万
-
财政年份:1995
-
负责人:KAREN S ZIER
-
依托单位:
ABNORMAL TCR/CD3 SIGNAL TRANSDUCTION IN CANCER
-
批准号:2443072
-
项目类别:
-
资助金额:$20.84万
-
财政年份:1995
-
负责人:KAREN S ZIER
-
依托单位:
ABNORMAL TCR/CD3 SIGNAL TRANSDUCTION IN CANCER
-
批准号:2104723
-
项目类别:
-
资助金额:$20.04万
-
财政年份:1995
-
负责人:KAREN S ZIER
-
依托单位:
DECREASED IL-2 SYNTHESIS IN TYPE I DIABETES
-
批准号:3145570
-
项目类别:
-
资助金额:$16.61万
-
财政年份:1990
-
负责人:KAREN S ZIER
-
依托单位:
DECREASED IL-2 SYNTHESIS IN TYPE I DIABETES
-
批准号:3145571
-
项目类别:
-
资助金额:$17.27万
-
财政年份:1990
-
负责人:KAREN S ZIER
-
依托单位:
DECREASED IL-2 SYNTHESIS IN TYPE I DIABETES
-
批准号:3145569
-
项目类别:
-
资助金额:$16.0万
-
财政年份:1990
-
负责人:KAREN S ZIER
-
依托单位:
CLASS II-IA EXPRESSION BY ACTIVATING T CELLS
-
批准号:3135737
-
项目类别:
-
资助金额:$15.69万
-
财政年份:1988
-
负责人:KAREN S ZIER
-
依托单位:
CLASS II (IA) EXPRESSION BY ACTIVATED T CELLS
-
批准号:3135733
-
项目类别:
-
资助金额:$15.24万
-
财政年份:1986
-
负责人:KAREN S ZIER
-
依托单位:
CLASS II (IA) EXPRESSION BY ACTIVATED T CELLS
-
批准号:3135736
-
项目类别:
-
资助金额:$5.87万
-
财政年份:1986
-
负责人:KAREN S ZIER
-
依托单位:
DETECTION OF HUMAN MINOR ALLOANTIGENS USING CTL LINES
-
批准号:3132297
-
项目类别:
-
资助金额:$12.95万
-
财政年份:1984
-
负责人:KAREN S ZIER
-
依托单位:
DETECTION OF HUMAN MINOR ALLOANTIGENS USING CTL LINES
-
批准号:3132299
-
项目类别:
-
资助金额:$13.5万
-
财政年份:1984
-
负责人:KAREN S ZIER
-
依托单位:
DETECTION OF HUMAN MINOR ALLOANTIGENS USING CTL LINES
-
批准号:3132300
-
项目类别:
-
资助金额:$14.2万
-
财政年份:1984
-
负责人:KAREN S ZIER
-
依托单位:
PILOT--ABNORMAL IMMUNE MECHANISMS IN INSULIN DEPENDENT DIABETICS
-
批准号:4689197
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:KAREN S ZIER
-
依托单位:
INDUCTION OF CLASS II GENE EXPRESSION IN ACTIVATED T CELLS
-
批准号:3954145
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:KAREN S ZIER
-
依托单位: